Biliang ZHANG, PhD
Professor, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, China
Biliang Zhang received his M.S. in Organic Chemistry from Fordham University in 1990, Ph.D. in Organic Chemistry with Prof. Ronald Breslow at Columbia University in 1995, and conducted his post-doctoral training with Prof. Thomas Cech at University of Colorado Boulder. In 1998 Dr. Zhang became an Assistant Professor of the Program in Molecular Medicine at University of Massachusetts Medical School. In 2004 he accepted a Principal Investigator role at the Guangzhou Institute of Biomedicine and Health of Chinese Academy of Sciences, where he currently holds a Professor position. Using diverse biological and chemical methodologies, Dr. Zhang’s lab studies the roles of RNA molecules in living cells. His particular interests are in the fields of non-coding RNAs, nucleic acid synthetic biology and therapeutics.
Lianghu QU, PhD
Professor, Director of Biotechnology Research Center, School of Life Sciences, Sun Yat-sen University, China
Lianghu Qu completed his undergraduate studies at Wuhan University in 1992 and received his Ph.D. degree from Paul-Sabatier University (Toulouse, France) in 1986. After a brief post-doctoral training at Centre de Biochimie et Genetique Cellulaires (CNRS, France), he joined Sun Yat-sen University, where he currently holds a Professor position at the Biotechnology Research Center and serves as Vice Director of Academic Commettee for State Key Laboratory of Molecular Biology. Dr. Qu’s scientific interests lie in the fields of non-coding RNAs structure, functions and applications.
Nucleic acids science plays a key role in precision medicine, genetic therapy and new solutions for human health. Continuous discovery of new RNA functions and constant emergence of innovative nucleic acids technologies are driving forces for the field and hold enormous promise for the future scientific and technological progress. The Canton Nucleic Acids Forum (CNAF) led by Nobel Prize winners is an international forum at the forefront of these developments, aims to push forward communications and collaborations in and abroad, and has been successfully held seven times since 2013. The CNAF has attracted high-profile speakers, including Nobel Prize winners, to highlight recent advances in nucleic-acid based medicine, scientific discoveries, diagnostics and industrial trends. It has been widely recognized as the premier forum in Asia for advancing nucleic acids research and drug development. The 2021 CNAF will feature 20+ globally prominent experts discussing the latest advances in nucleic acids research and development.
© 2013-18 China Nucleic Acids Forum (CNAF)